Services
We provide two services: OncoAct and Hartwig Sequencing Services.
OncoAct
Cancer is caused by DNA mutations. To find these mutations, we developed OncoAct. OncoAct is a complete DNA test that can provide physicians with additional information about clinically relevant characteristics of a tumor (biomarkers) that may also be predictive of the response to treatment.
Changes in the genetic profile (mutations) sometimes provide clues to a potential treatment that can directly target these mutations. This is known as targeted therapy.
In addition, the OncoAct report contains possible leads for trials or experimental drugs.
Sequencing Services
We sequence and analyze DNA for research purposes.
By using WGS, we took a step forward in molecular diagnostics in our department from the analysis of less than 100 genes to approximately 20,000 genes per patient. This provides an enormous amount of valuable information, not only for the patient of today, but also for the patient of the future.